🇺🇸 FDA
Pipeline program

CISPLATIN, CARBOPLATIN, PACLITAXEL, PEMETREXED, LIBTAYO 350 mg concentrate for solution for infusion.

Hyperbolic

Phase 2 small_molecule active

Quick answer

CISPLATIN, CARBOPLATIN, PACLITAXEL, PEMETREXED, LIBTAYO 350 mg concentrate for solution for infusion. for non-small cell lung cancer (NSCLC) is a Phase 2 program (small_molecule) at Talion with 1 ClinicalTrials.gov record(s).

Program details

Company
Talion
Indication
non-small cell lung cancer (NSCLC)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials